This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
November 04, 2020
Orexo Interim Report Q3 2020
November 03, 2020
Vicore announces changes in management team
November 03, 2020
GenSight Biologics reports validation of LUMEVOQ® Marketing Authorisation Application (MAA) by European Medicines Agency
November 03, 2020
Q3 2020 General Market Overview
November 02, 2020
Pulmonx Announces Additional 16 Million Covered Lives for The Zephyr® Valve, a Minimally Invasive Treatment Option for Severe Emphysema (COPD)
November 02, 2020
Fusion Pharmaceuticals Announces Collaboration With AstraZeneca To Develop And Commercialize Next-Generation Radiopharmaceuticals And Combination Therapies
November 02, 2020
Vicore strengthens its pipeline with the acquisition of novel AT2R agonists and decides on an issue in kind of 142,054 shares
November 02, 2020
Fusion Pharmaceuticals Appoints Barbara Duncan As Chairperson Of The Board Of Directors
October 30, 2020
Strongbridge Biopharma plc Reports Third Quarter 2020 Financial Results and Provides Corporate Update
October 29, 2020
Healthtech company Doctrin looks towards further expansion – hires new CTO and a Vice President International